HRSA-23-084: Alliance for Innovation on Maternal Health (AIM) Technical Assistance Center
Closed
This grant is closed. A newer notice from the same program is forecast: Alliance for Innovation on Maternal Health (AIM) Technical Assistance Center (HRSA-27-027). Status: Expected deadline November 13, 2026. It is in our archive of Health Resources and Services Administration notices from 2023.
Health Resources and Services Administration offered grants of up to $3.0 million to the applicants described in the notice. It expected to make one award worth $3.0 million in total. Applications closed on May 9, 2023.
From the official notice on Grants.gov, last changed March 10, 2023. Checked November 7, 2026.
- Award ceiling$3.0 million
- Total funding$3.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| HRSA-27-027 | August 11, 2026 | Expected deadline November 13, 2026 | Forecast |
Key dates
| Posted | March 10, 2023 |
|---|---|
| Deadline | May 9, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include any domestic public or private entity. Domestic faith based and community-based organizations, tribes, and tribal organizations are also eligible to apply
Is this a realistic fit?
- Past Special Projects of Regional and National Significance awards averaged $1.6 million; this notice allows up to $3.0 million per award.
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the Alliance for Innovation on Maternal Health (AIM) Technical Assistance Center. HRSA/MCHB seeks to expand implementation and reach of AIM program activities by funding the AIM Technical Assistance (TA) Center to support all 50 states, the District of Columbia (D.C.), jurisdictions, U.S. territories, tribal communities,1 and birthing facilities that are participating in the AIM program through the provision of TA to increase birthing facility engagement, support bundle implementation and sustainability, manage reporting and analysis of state AIM data, and promote safe care for pregnant and postpartum people. These efforts are designed to meet the intent of the legislation which is “identifying, developing, or disseminating best practices to improve maternal health care quality and outcomes, improve maternal and infant health, and eliminate preventable maternal mortality and severe maternal morbidity”. This TA Center will be one of two components of the AIM Program. The second AIM component will be the HRSA-23-066 AIM Capacity program to support states, capacity to implement AIM and expand the reach, depth, and quality of AIM implementation throughout the United States. For more details, see Program Requirements and Expectations. Program Goal: The goal of this initiative is to improve maternal health and safety in the United States by increasing access to safe, reliable, quality care. Primary Program Objectives: The objectives to be accomplished during the period of performance to support AIM program’s goal include: By August 31, 2027, the AIM TA Center will: • Increase the technical assistance provided to participating AIM states for implementing AIM patient safety bundles; • Increase the number of hospitals and other birthing facility settings implementing patient safety bundles; • Increase the overall number of core bundles being implemented and/or sustained; • Support widespread implementation of the core patient safety bundles, all of which include elements focused on the provision of respectful, equitable, and supportive care; and, • Provide TA to support AIM states in reporting key measures by race and ethnicity, at a minimum, to evaluate disparities.
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-027, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-23-084 still open?
No. It closed on May 9, 2023. A newer notice is forecast: HRSA-27-027, expected deadline November 13, 2026.
Who can apply for Alliance for Innovation on Maternal Health (AIM) Technical Assistance Center?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Alliance for Innovation on Maternal Health (AIM) Technical Assistance Center?
Closed May 9, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $3.0 million each. About $3.0 million in total for one award.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)